No PHI 15-minute fit review for GLP-1 clinics

Catch GLP-1 refill, side-effect, access, and confidence risks between visits.

PulseLog by HealthPulseAI turns no-PHI weekly check-ins into a staff-ready intervention queue for weight-loss, primary-care, DPC, metabolic, and medspa teams running GLP-1 programs.

Request 30-day pilot reviewReview no-PHI scope

First review uses synthetic or de-identified operational data only. Real patient identifiers, PHI, production storage, and live clinic workflows require HIPAA/BAA/compliance approval before use.

30-day pilot shape

1 clinic / 25–50 GLP-1 patients

Start with synthetic PulseLog check-ins, then graduate only after compliance sign-off.

  • • Weekly green/yellow/red intervention queue
  • • Side-effect, hydration, and confidence risk trends
  • • Refill/access and coverage-friction report
  • • Staff action readout and continuation recommendation

Why this wedge is urgent now

A 2025 JAMA Network Open cohort study of adults with overweight or obesity reported that most patients discontinued GLP-1 therapy within one year, with higher discontinuation among patients without type 2 diabetes. Clinics do not need another broad wellness app; they need earlier signals that a patient is about to miss, pause, ration, or abandon therapy.

Source: JAMA Network Open, Discontinuation and Reinitiation of GLP-1 Receptor Agonists

Synthetic queue mockup

Staff see who needs action before the next scheduled visit.

Example rows below are synthetic aliases. They illustrate the staff workflow without exposing patient names, contact details, prescription identifiers, or clinical notes.

PT-014Red

Signal: Missed dose + dehydration concern

Next action: Clinician escalation policy

PT-022Yellow

Signal: Refill/access issue

Next action: Staff access check

PT-031Yellow

Signal: Nausea score increased

Next action: Side-effect protocol review

PT-047Green

Signal: Dose taken, confidence stable

Next action: Routine encouragement

What the first pilot can include

  • • Patient alias only
  • • Medication family
  • • Dose phase
  • • Dose taken / missed / delayed
  • • Side-effect severity bands
  • • Refill, access, and coverage friction
  • • Confidence score
  • • Staff follow-up requested

What must stay out of the first request

  • • Names or initials
  • • Date of birth
  • • MRN or prescription IDs
  • • Phone numbers or emails
  • • Addresses or member IDs
  • • Screenshots or portal messages
  • • Free-text clinical notes

After you request a review

The first step is a 15-minute no-PHI fit review, not a data handoff.

Clinic teams get a clear operating discussion before any pilot is approved: who owns follow-up, which non-identifying signals matter, and whether a 30-day PulseLog pilot is worth scoping.

1. Confirm the workflow owner

Identify who owns between-visit GLP-1 follow-up without sending patient charts, exports, or screenshots.

2. Map the no-PHI pilot queue

Use synthetic examples to choose the refill, side-effect, access, and confidence signals staff would review weekly.

3. Decide on the 30-day pilot fit

Leave with a scoped go/no-go note, compliance prerequisites, and next-step owner before any live workflow.

Want the 30-day pilot packet?

We will review fit, clinic workflow, and no-PHI pilot inputs before discussing any live patient-data or production workflow. Do not include PHI in the first email.

Request GLP-1 pilot review